Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia

Roberto Ciarcia, Sara Damiano, Maria Valeria Puzio, Serena Montagnaro, Francesco Pagnini, Carmen Pacilio, Giuseppe Caparrotti, Cristiana Bellan, Tiziana Garofano, Maria Sole Polito, Antonio Giordano, Salvatore Florio

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kinase. In this study we evaluated the in vivo effect of DAS, NIL, and IM on intracellular calcium concentration, oxidative stress, and apoptosis in peripheral blood leukocytes of 45 newly diagnosed patients with chronic myeloid leukaemia (CML-PBM). Our data demonstrated that treatment with DAS and NIL showed an higher modulating potential than IM on intracellular calcium concentration by inhibiting the thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, and Lithium (Li) an inositol 1,4,5-triphosphate (InsP3) receptor inhibitor activities. Moreover our data demonstrated that NIL and DAS have significantly increased apoptosis more than IM by involving both intracellular calcium signaling as well as oxidative stress. The acquisition of the oxidative stress and calcium channels receptors values data could help the hematologist to modulate and improve the treatment of chronic myeloid leukaemia (CML) pathology.

Original languageEnglish
Pages (from-to)680-687
Number of pages8
JournalJournal of Cellular Physiology
Volume231
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Oxidative stress
Oxidative Stress
Phosphotransferases
Calcium
Apoptosis
Calcium-Sensing Receptors
Inositol 1,4,5-Trisphosphate Receptors
Inositol 1,4,5-Trisphosphate
Thapsigargin
Calcium Signaling
Calcium-Transporting ATPases
Sarcoplasmic Reticulum
Pathology
Calcium Channels
Therapeutics
Lithium
Drug Resistance
Endoplasmic Reticulum
Protein-Tyrosine Kinases

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Ciarcia, R., Damiano, S., Puzio, M. V., Montagnaro, S., Pagnini, F., Pacilio, C., ... Florio, S. (2016). Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia. Journal of Cellular Physiology, 231(3), 680-687. https://doi.org/10.1002/jcp.25118

Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia. / Ciarcia, Roberto; Damiano, Sara; Puzio, Maria Valeria; Montagnaro, Serena; Pagnini, Francesco; Pacilio, Carmen; Caparrotti, Giuseppe; Bellan, Cristiana; Garofano, Tiziana; Polito, Maria Sole; Giordano, Antonio; Florio, Salvatore.

In: Journal of Cellular Physiology, Vol. 231, No. 3, 01.03.2016, p. 680-687.

Research output: Contribution to journalArticle

Ciarcia, R, Damiano, S, Puzio, MV, Montagnaro, S, Pagnini, F, Pacilio, C, Caparrotti, G, Bellan, C, Garofano, T, Polito, MS, Giordano, A & Florio, S 2016, 'Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia', Journal of Cellular Physiology, vol. 231, no. 3, pp. 680-687. https://doi.org/10.1002/jcp.25118
Ciarcia, Roberto ; Damiano, Sara ; Puzio, Maria Valeria ; Montagnaro, Serena ; Pagnini, Francesco ; Pacilio, Carmen ; Caparrotti, Giuseppe ; Bellan, Cristiana ; Garofano, Tiziana ; Polito, Maria Sole ; Giordano, Antonio ; Florio, Salvatore. / Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia. In: Journal of Cellular Physiology. 2016 ; Vol. 231, No. 3. pp. 680-687.
@article{a41c425951d64fdc9588df3b11899cd6,
title = "Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia",
abstract = "To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kinase. In this study we evaluated the in vivo effect of DAS, NIL, and IM on intracellular calcium concentration, oxidative stress, and apoptosis in peripheral blood leukocytes of 45 newly diagnosed patients with chronic myeloid leukaemia (CML-PBM). Our data demonstrated that treatment with DAS and NIL showed an higher modulating potential than IM on intracellular calcium concentration by inhibiting the thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, and Lithium (Li) an inositol 1,4,5-triphosphate (InsP3) receptor inhibitor activities. Moreover our data demonstrated that NIL and DAS have significantly increased apoptosis more than IM by involving both intracellular calcium signaling as well as oxidative stress. The acquisition of the oxidative stress and calcium channels receptors values data could help the hematologist to modulate and improve the treatment of chronic myeloid leukaemia (CML) pathology.",
author = "Roberto Ciarcia and Sara Damiano and Puzio, {Maria Valeria} and Serena Montagnaro and Francesco Pagnini and Carmen Pacilio and Giuseppe Caparrotti and Cristiana Bellan and Tiziana Garofano and Polito, {Maria Sole} and Antonio Giordano and Salvatore Florio",
year = "2016",
month = "3",
day = "1",
doi = "10.1002/jcp.25118",
language = "English",
volume = "231",
pages = "680--687",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia

AU - Ciarcia, Roberto

AU - Damiano, Sara

AU - Puzio, Maria Valeria

AU - Montagnaro, Serena

AU - Pagnini, Francesco

AU - Pacilio, Carmen

AU - Caparrotti, Giuseppe

AU - Bellan, Cristiana

AU - Garofano, Tiziana

AU - Polito, Maria Sole

AU - Giordano, Antonio

AU - Florio, Salvatore

PY - 2016/3/1

Y1 - 2016/3/1

N2 - To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kinase. In this study we evaluated the in vivo effect of DAS, NIL, and IM on intracellular calcium concentration, oxidative stress, and apoptosis in peripheral blood leukocytes of 45 newly diagnosed patients with chronic myeloid leukaemia (CML-PBM). Our data demonstrated that treatment with DAS and NIL showed an higher modulating potential than IM on intracellular calcium concentration by inhibiting the thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, and Lithium (Li) an inositol 1,4,5-triphosphate (InsP3) receptor inhibitor activities. Moreover our data demonstrated that NIL and DAS have significantly increased apoptosis more than IM by involving both intracellular calcium signaling as well as oxidative stress. The acquisition of the oxidative stress and calcium channels receptors values data could help the hematologist to modulate and improve the treatment of chronic myeloid leukaemia (CML) pathology.

AB - To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kinase. In this study we evaluated the in vivo effect of DAS, NIL, and IM on intracellular calcium concentration, oxidative stress, and apoptosis in peripheral blood leukocytes of 45 newly diagnosed patients with chronic myeloid leukaemia (CML-PBM). Our data demonstrated that treatment with DAS and NIL showed an higher modulating potential than IM on intracellular calcium concentration by inhibiting the thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, and Lithium (Li) an inositol 1,4,5-triphosphate (InsP3) receptor inhibitor activities. Moreover our data demonstrated that NIL and DAS have significantly increased apoptosis more than IM by involving both intracellular calcium signaling as well as oxidative stress. The acquisition of the oxidative stress and calcium channels receptors values data could help the hematologist to modulate and improve the treatment of chronic myeloid leukaemia (CML) pathology.

UR - http://www.scopus.com/inward/record.url?scp=84949099218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949099218&partnerID=8YFLogxK

U2 - 10.1002/jcp.25118

DO - 10.1002/jcp.25118

M3 - Article

VL - 231

SP - 680

EP - 687

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 3

ER -